Talal Hilal 🩺

Internist, hematologist-oncologist, transplant/CAR-T physician for lymphoma/CLL. Interest in clinical reasoning, risk, pragmatism.

[Talal Hilal 🩺 @THilalMD]

I did not expect this piece to resonate with so many people. This is dedicated to all the clinicians in the trenches. https://t.co/BfDLUH5lmq

[Blood Cancers Today @Blood_Cancers]

🎉 Our latest feature is out now! 🎉

We took a deep dive into the use of #MRD in hematologic malignancies with Elias Jabbour, MD, of @MDAndersonNews; @DrOlaLandgren of @SylvesterCancer; and @THilalMD of @MayoClinic.

📚 Read here! https://t.co/SfGt4CbIKY

[chadi nabhan MD, MBA, FACP @chadinabhan]

Don’t miss @THilalMD speaking to me on #HemOnc Pulse podcast on MRD - @Blood_Cancers
👇👇👇👇👇👇

[Talal Hilal 🩺 @THilalMD]

@chadinabhan @Blood_Cancers Thank you for having me! You are a skilled host

[Blood Cancers Today @Blood_Cancers]

🙌 ICYMI: @THilalMD, of the @MayoClinic, joined @chadinabhan on "The HemOnc Pulse" last week to talk about #MRD and whether he uses it to make treatment decisions in #CLL.

🎧 https://t.co/IEF5nG7xvv

[Talal Hilal 🩺 @THilalMD]

@infonbpas, a physician-led organization providing another pathway for continuous board certification. Looking forward to see this supplant #ABIM and its extortion practices

[Talal Hilal 🩺 @THilalMD]

My new essay in @TheLancetHaem on clinical trials

[Talal Hilal 🩺 @THilalMD]

@Eddie_Cliff @PallawiTorkaMD @barttels2 @dgermain21 @AaronGoodman33 @LNastoupilMD @WomenInLymphoma @mshadman @DrAEvens @majorajay If CR post bispecific or lonca-T and the likes I would consolidate with allo-HSCT. Not clear to me if bispecifics are curative here if given in 3rd line (especially if previous CAR-T). EBMT and CIBMTR datasets suggests CR pre-allo is best, but there are long term cures with PR..

[Fausto A. Rios Olais @faustor]

Come to see our work (poster 1916), a meta-analysis about the association of MRD with PFS in CLL. Thanks @THilalMD for the opportunity to work on this after my last year observership @ASH_hematology #ASH23 #CLLsm

[Talal Hilal 🩺 @THilalMD]

Don't know who created this but very accurate

[Talal Hilal 🩺 @THilalMD]

I'm also on call this weekend and it feels great! #ASH23 @AaronGoodman33

[Talal Hilal 🩺 @THilalMD]

Not good

[Benlazar S M A @smbenlazar]

Comparable Survival of Treatment Naïve TP53 Mutated Acute Myeloid Leukemia Treated with Hypomethylating Agent Compared to Hypomethylating Agent Plus Venetoclax Based Therapy https://t.co/n5Y8GGq09r #ASH23

[chadi nabhan MD, MBA, FACP @chadinabhan]

This episode of #HealthcareUnfiltered podcast the week of ⁦@ASH_hematology⁩ #ASH23 is W the inspiring ⁦@ARosenthalDO⁩ of ⁦@MayoClinic⁩ talking caring for AYA pts w cancer. Alison who survived cancer shares all.

Here’s the link & a clip:

https://t.co/dsN8uhfS3Q

[Talal Hilal 🩺 @THilalMD]

@barttels2 @zamishka Jonathan Eig's Ali is my favorite

[Thomas Sowell Quotes @ThomasSowell]

People who enjoy meetings should not be in charge of anything.

[Talal Hilal 🩺 @THilalMD]

@DavidSteensma Well said. I'm afraid there won't be enough clinicians walking down these bridges by the time it's built

[Talal Hilal 🩺 @THilalMD]

@AaronGoodman33 I might try that in the new year. How are you with Epic?

[Dr. Glaucomflecken @DGlaucomflecken]

Med students should be banned from participating in research

[Talal Hilal 🩺 @THilalMD]

@AaronGoodman33 I remember a time when the hospitalist used to say “I don’t agree with all these recs, let’s not order all these esoteric tests” but that seems to be a remnant of the past

[Talal Hilal 🩺 @THilalMD]

@AAMortazavi #ProudFather

[Talal Hilal 🩺 @THilalMD]

@smaliske07 If high-risk, IT MTX with every cycle x 6. If low-risk, just 1 diagnostic and therapeutic LP and 3 cycles of R-EPOCH.

[Talal Hilal 🩺 @THilalMD]

Another extremely useful trial suggesting CODOX-M/IVAC is no better than da-EPOCH-R for Burkitt lymphoma without CNS dx.

[The Lancet Haematology @TheLancetHaem]

New: Final results from the phase 3 HOVON/SAKK trial, comparing R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma
https://t.co/74MH7fEAn6